Pharmaceutical executive with over 30 years of experience in pharmaceutical development and drug delivery, including pediatric products. Daniel retired from Janssen R&D LLC (Johnson & Johnson) as Sr. Scientific Director, where he co-chaired the J&J internal Pediatric Formulation Network. He is currently the Head of the Pediatric Center of Excellence at NGT BioPharma Consulting LLC. He is a CMC consultant for NIH/NIAID/DAIDS and for WHO’s Global Accelerator for Paediatric Formulation Development (GAP-f). 

Daniel holds a degree in pharmacy (ETH Zurich) and a doctorate from the University of Lausanne. He is a member of the Pediatric Working Group of the International Consortium (IQ) for Quality in Pharmaceutical Development and has been appointed formulation expert for the pan-European "Conect4Children" initiative. Daniel is a founding member of the society of “Paediatric Medicines and Health Initiative”, based in Mumbai, India. In 2020, he joined Johns Hopkins University, School of Medicine, All Children’s Hospital in St. Petersburg, FL as adjunct assistant Professor. Daniel is a speaker and moderator at domestic and international conferences with a focus and passion for “developing better medicines for children”.